Executive Functioning

A BRIEF COGNITIVE-BEHAVIORAL INTERVENTION for TREATING DEPRESSION and PANIC DISORDER in PATIENTS WITH NONCARDIAC CHEST PAIN: A 24-WEEK RANDOMIZED CONTROLLED TRIAL.

A BRIEF COGNITIVE-BEHAVIORAL INTERVENTION FOR TREATING DEPRESSION AND PANIC DISORDER IN PATIENTS WITH NONCARDIAC CHEST PAIN: A 24-WEEK RANDOMIZED CONTROLLED TRIAL.

Depress Anxiety. 2013 Apr 26;
van Beek MH, Oude Voshaar RC, Beek AM, van Zijderveld GA, Visser S,… Continue reading →

[Compulsory Hospitalisation of Patients Suffering From Severe Drug or Alcohol Addiction.]

[Compulsory hospitalisation of patients suffering from severe drug or alcohol addiction.]

Tijdschr Psychiatr. 2013; 55(4): 269-277
Höppener PE, Godschalx-Dekker JA, van de Wetering BJ

summary BACKGROUND: Psychiatrists treating patients with drug and alcohol addiction currently consider these afflicions to… Continue reading →

Alcohol Use and Cerebral White Matter Compromise in Adolescence.

Alcohol use and cerebral white matter compromise in adolescence.

Addict Behav. 2013 Mar 15; 38(7): 2295-2305
Elofson J, Gongvatana W, Carey KB

Alcohol use is typically initiated during adolescence, a period known to be critical in neurodevelopment. The adolescent… Continue reading →

Trends in Opioid Analgesics Sales to Community Pharmacies and Hospitals in Italy (2000-2010).

Trends in opioid analgesics sales to community pharmacies and hospitals in Italy (2000-2010).

Minerva Anestesiol. 2013 Apr 5;
Caraceni AT, Brunelli C, Rocco P, Minghetti P

Background: Opioid consumption data in Italy have been widely studied. However, only aggregate… Continue reading →

The Glucocorticoid Antagonist RU-486 Suppresses HIV Infectivity and Replication.

The Glucocorticoid Antagonist RU-486 Suppresses HIV Infectivity and Replication.

J Neuropsychiatry Clin Neurosci. 2013 Mar 1; 25(1): 51-7
Benton TD, Lynch KG, Dubé B, Gettes DR, Tustin NB, Metzger DS, Blume J, Douglas SD, Evans DL

The effects of… Continue reading →

Biomarkers and the Future of Treatment for Depression.

Biomarkers and the Future of Treatment for Depression.

Cerebrum. 2012 5; 2012: 6
Toups M, Trivedi MH

Doctors have a variety of drug options for treatment of depression. But there is currently no way to determine which antidepressant will… Continue reading →

Neuroplasticity-Based Brain Stimulation Interventions in the Study and Treatment of Schizophrenia: A Review.

Neuroplasticity-based brain stimulation interventions in the study and treatment of schizophrenia: a review.

Can J Psychiatry. 2013 Feb; 58(2): 93-8
Rajji TK, Rogasch NC, Daskalakis ZJ, Fitzgerald PB

We reviewed novel brain stimulation approaches that modify neuroplasticity and are… Continue reading →

Addiction Rehab: Worming Our Way to Alzheimer’s Disease Drug Discovery.

Worming our way to Alzheimer’s disease drug discovery.

Filed under: Addiction Rehab

Biol Psychiatry. 2013 Mar 1; 73(5): 396-8
Iyer S, Pierce-Shimomura JT

HubMed – addiction

 

Modafinil Modulates Resting-State Functional Network Connectivity and Cognitive Control in Alcohol-DependentPatients.

Filed… Continue reading →

Rehab Centers: Acute Viral Infections of the Central Nervous System in Immunocompetent Adults: Diagnosis and Management.

Acute Viral Infections of the Central Nervous System in Immunocompetent Adults: Diagnosis and Management.

Filed under: Rehab Centers

Drugs. 2013 Feb 2;
Studahl M, Lindquist L, Eriksson BM, Günther G, Bengner M, Franzen-Röhl E, Fohlman J, Bergström T, Aurelius… Continue reading →

Easy Quantitative Methodology to Assess Visual-Motor Skills.

Easy quantitative methodology to assess visual-motor skills.

Filed under: Rehab Centers

Neuropsychiatr Dis Treat. 2013; 9: 93-100
Chiappedi M, Toraldo A, Mandrini S, Scarpina F, Aquino M, Magnani FG, Bejor M

Visual-motor skills are the basis for a great… Continue reading →